Insider · CIK 0001843119
Enoch Kariuki
Files at ZNTL (Zentalis Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Enoch Kariuki files SEC Form 4 as director at ZNTL (Zentalis Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Enoch Kariuki has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Common Stock | +57,100 | $0.00 | $0 | 194,465 | Jun 18, 2026 |
| Jun 17, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Common Stock | +57,603 | $0.00 | $0 | 137,365 | Jun 18, 2025 |
Questions about Enoch Kariuki
Answered from the filings on this page, as of the latest one.
Is Enoch Kariuki buying or selling?
Enoch Kariuki has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Enoch Kariuki's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Enoch Kariuki has 0.
Where does Enoch Kariuki file Form 4?
Enoch Kariuki has filed Form 4 at ZNTL (Zentalis Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.